Concept
Key Discussion and Conclusion Points from the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study
- There is some research to support CQ's (and HCQ its derivative) use as an antiviral treatment for viruses that involve severe immune responses
- CQ has been shown in one study to stop SARS-CoV-2 from replicating in vitro
- There is data to suggest that HCQ can counteract the cytokine storm that can occur with COVID-19
- More studies need to be conducted to more concretely determine HCQ's efficacy in fighting COVID-19 for the wider population
0
1
Updated 2020-08-10
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Methods of the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study
Results of the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study
Limitations in the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study
Key Discussion and Conclusion Points from the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study